Suppr超能文献

造血干细胞移植(HSCT)和骨髓移植(BMT)儿童幸存者的人口统计学、医学及治疗变量与健康相关生活质量(HRQOL)的综述

A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood.

作者信息

Reinfjell Trude, Tremolada Marta, Zeltzer Lonnie K

机构信息

Department of Psychology, Norwegian University of Science and TechnologyTrondheim, Norway; Department of Child and Adolescent Psychiatry, St. Olavs University HospitalTrondheim, Norway.

Department of Developmental and Social Psychology, University of Padua Padua, Italy.

出版信息

Front Psychol. 2017 Mar 10;8:253. doi: 10.3389/fpsyg.2017.00253. eCollection 2017.

Abstract

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin of the stem cells. HSCT is associated with adverse side effects, prolonged hospitalization, and isolation. Previous studies have shown that survivors of HSCT are at particularly high risk for developing late effects and medical complications, and thus, in addition to survival, quality of life in survivors of HSCT is an important outcome. This review summarizes and distills findings on the health-related quality of life (HRQOL) of long-term childhood cancer survivors of HSCT and examines significant sociodemographic, medical, disease and treatment correlates of HRQOL, as well as the methodology of the studies (instruments, type of studies, timing of assessment, type of transplantation). Because previous reviews covered the studies published before 2006, this review searched three databases published between January, 2006, and August, 2016. The search identified nine studies, including 2 prospective cohort studies and 7 cross-sectional studies. All studies reported a follow-up time of >5 years. The review found that HRQOL is significantly impacted over time following childhood HSCT, with salient correlates of HRQOL found to be presence of a severe chronic health or major medical condition, graft vs. host disease (GVHD), or pain. Continual evaluation of HRQOL must be integrated into long-term follow-up after childhood HSCT, and intervention should be offered for those survivors with poor HRQOL. Longitudinal studies should be emphasized in future research to allow for predictor models of resilience and poor HRQOL.

摘要

造血干细胞移植(HSCT)是儿童癌症疾病复发且常规治疗失败后的标准治疗方法,或作为某些高危癌症的一线治疗方法。由于造血干细胞可在骨髓中找到(以前称为骨髓移植)或外周血中找到,因此无论干细胞来源如何,我们都将HSCT视为包含所有造血干细胞移植类型。HSCT会带来不良副作用、延长住院时间并需要隔离。先前的研究表明,HSCT幸存者发生晚期效应和医疗并发症的风险特别高,因此,除了生存之外,HSCT幸存者的生活质量也是一个重要的结果。本综述总结并提炼了关于HSCT长期儿童癌症幸存者健康相关生活质量(HRQOL)的研究结果,并研究了HRQOL的重要社会人口统计学、医学、疾病和治疗相关因素,以及研究方法(工具、研究类型、评估时间、移植类型)。由于先前的综述涵盖了2006年之前发表的研究,本综述检索了2006年1月至2016年8月期间发表的三个数据库。检索到九项研究,包括两项前瞻性队列研究和七项横断面研究。所有研究报告的随访时间均>5年。综述发现,儿童HSCT后随着时间推移,HRQOL受到显著影响,发现HRQOL的显著相关因素为存在严重慢性健康问题或重大疾病、移植物抗宿主病(GVHD)或疼痛。必须将HRQOL的持续评估纳入儿童HSCT后的长期随访中,对于HRQOL较差的幸存者应提供干预措施。未来研究应强调纵向研究,以便建立恢复力和HRQOL较差的预测模型。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验